A Guide to Taking CBD Sublingually

January 16, 2020 16:00:43

Cannabidiol has without a doubt taken the medical, health and wellness communities with a bang. The hemp extract has been legal for only a year, but already has a booming market that experts predict will hit $20 billion by 2024. On top of that, the country has been experiencing a wave of cannabis legalization, both recreational and medicinal, and CBD is a big part of that.

Although there‚Äôs little scientific proof, consumers have claimed the chemical offers relief against a variety of conditions from anxiety and chronic pain to insomnia. Last June, the FDA approved a CBD based drug to help treat seizures in two…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.